Liver Cancer Therapeutics Market Share

Geographically, the global liver cancer therapeutics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America region is expected to hold largest industry share by 2036, owing to high awareness about liver cancer, presence of well-established healthcare infrastructure, and easy drug availability. According to the U.S. Centers for Disease Control & Prevention (CDC), around 24,500 men and 10,000 women get affected from liver cancer every year in the U.S., while about 18,600 men and 9,000 women die from the disease.

Asia-Pacific region is projected to witness growth at the highest rate over the forecast period on the back of rapid increase in the liver cancer patients in the region, mainly in highly populated countries, such as India & China, and advancing healthcare. According to the World Cancer Research Fund (WCRF), Mongolia had the highest rate of liver cancer in the world in 2018, while Thailand, China, and South Korea ranked at 8^th, 9^th, and 10^th respectively.